文献
J-GLOBAL ID:200902264698113030
整理番号:08A0168419
選択的HDAC1/HDAC2阻害剤(SHI-1:2)によるヒストン脱アセチル化酵素(HDAC)の内部キャビティの探索
Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2)
著者 (26件):
METHOT Joey L.
(Dep. of Drug Design and Optimization, Merck Res. Laboratories, 33 Avenue Louis Pasteur, Boston, MA 02115, USA)
,
CHAKRAVARTY Prasun K.
(Dep. of Medicinal Chemistry, Merck Res. Laboratories, 126 E. Lincoln Avenue, Rahway, NJ 07065, USA)
,
CHENARD Melissa
(Dep. of Oncology and Pharmacology, Merck Res. Laboratories, 33 Avenue Louis Pasteur, Boston, MA 02115, USA)
,
CLOSE Joshua
(Dep. of Drug Design and Optimization, Merck Res. Laboratories, 33 Avenue Louis Pasteur, Boston, MA 02115, USA)
,
CRUZ Jonathan C.
(Dep. of Oncology and Pharmacology, Merck Res. Laboratories, 33 Avenue Louis Pasteur, Boston, MA 02115, USA)
,
DAHLBERG William K.
(Dep. of Drug Design and Optimization, Merck Res. Laboratories, 33 Avenue Louis Pasteur, Boston, MA 02115, USA)
,
FLEMING Judith
(Dep. of Cancer Biology and Therapeutics, Merck Res. Laboratories, 33 Avenue Louis Pasteur, Boston, MA 02115, USA)
,
HAMBLETT Christopher L.
(Dep. of Drug Design and Optimization, Merck Res. Laboratories, 33 Avenue Louis Pasteur, Boston, MA 02115, USA)
,
HAMILL Julie E.
(Dep. of Drug Design and Optimization, Merck Res. Laboratories, 33 Avenue Louis Pasteur, Boston, MA 02115, USA)
,
HARRINGTON Paul
(Dep. of Drug Design and Optimization, Merck Res. Laboratories, 33 Avenue Louis Pasteur, Boston, MA 02115, USA)
,
HARSCH Andreas
(Dep. of Drug Design and Optimization, Merck Res. Laboratories, 33 Avenue Louis Pasteur, Boston, MA 02115, USA)
,
HEIDEBRECHT Richard
(Dep. of Drug Design and Optimization, Merck Res. Laboratories, 33 Avenue Louis Pasteur, Boston, MA 02115, USA)
,
HUGHES Bethany
(Dep. of Drug Design and Optimization, Merck Res. Laboratories, 33 Avenue Louis Pasteur, Boston, MA 02115, USA)
,
JUNG Joon
(Dep. of Drug Design and Optimization, Merck Res. Laboratories, 33 Avenue Louis Pasteur, Boston, MA 02115, USA)
,
KENIFIC Candia M.
(Dep. of Oncology and Pharmacology, Merck Res. Laboratories, 33 Avenue Louis Pasteur, Boston, MA 02115, USA)
,
KRAL Astrid M.
(Dep. of Cancer Biology and Therapeutics, Merck Res. Laboratories, 33 Avenue Louis Pasteur, Boston, MA 02115, USA)
,
MEINKE Peter T.
(Dep. of Medicinal Chemistry, Merck Res. Laboratories, 126 E. Lincoln Avenue, Rahway, NJ 07065, USA)
,
MIDDLETON Richard E.
(Dep. of Drug Design and Optimization, Merck Res. Laboratories, 33 Avenue Louis Pasteur, Boston, MA 02115, USA)
,
OZEROVA Nicole
(Dep. of Cancer Biology and Therapeutics, Merck Res. Laboratories, 33 Avenue Louis Pasteur, Boston, MA 02115, USA)
,
SLOMAN David L.
(Dep. of Drug Design and Optimization, Merck Res. Laboratories, 33 Avenue Louis Pasteur, Boston, MA 02115, USA)
,
STANTON Matthew G.
(Dep. of Drug Design and Optimization, Merck Res. Laboratories, 33 Avenue Louis Pasteur, Boston, MA 02115, USA)
,
SZEWCZAK Alexander A.
(Dep. of Drug Design and Optimization, Merck Res. Laboratories, 33 Avenue Louis Pasteur, Boston, MA 02115, USA)
,
TYAGARAJAN Sriram
(Dep. of Medicinal Chemistry, Merck Res. Laboratories, 126 E. Lincoln Avenue, Rahway, NJ 07065, USA)
,
WITTER David J.
(Dep. of Drug Design and Optimization, Merck Res. Laboratories, 33 Avenue Louis Pasteur, Boston, MA 02115, USA)
,
PAUL SECRIST J.
(Dep. of Cancer Biology and Therapeutics, Merck Res. Laboratories, 33 Avenue Louis Pasteur, Boston, MA 02115, USA)
,
MILLER Thomas A.
(Dep. of Drug Design and Optimization, Merck Res. Laboratories, 33 Avenue Louis Pasteur, Boston, MA 02115, USA)
資料名:
Bioorganic & Medicinal Chemistry Letters
(Bioorganic & Medicinal Chemistry Letters)
巻:
18
号:
3
ページ:
973-978
発行年:
2008年02月01日
JST資料番号:
W0248A
ISSN:
0960-894X
資料種別:
逐次刊行物 (A)
発行国:
オランダ (NLD)
言語:
英語 (EN)